ReviewDiagnostics (Basel, Switzerland)2026
Applications of Machine Learning for Early Diagnosis and Prognosis of Chronic Kidney Disease: Current Evidence.
Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, interest in machine learning applications has grown rapidly, particularly in the medical domain, where large amounts of data are available for training these models. This review focuses on the potential of machine learning for early diagnosis and prognosis of chronic kidney disease (CKD) by examining the most recent literature. Articles published from 2016 to 2025 were collected from online databases such as PubMed, Web of Science, and Embase. After abstract and full-text screening, 57 articles were included in the results section. Machine learning was applied to clinical and laboratory data, medical imaging, urine samples, retinal images, and at-home measurements to diagnose CKD and predict CKD progression and related complications. Although many studies reported high discriminatory performance, the evidence base was dominated by retrospective, single-center, and methodologically heterogeneous studies, with frequent high-risk-of-bias findings and limited external validation. Furthermore, most published models are not yet sufficiently validated for clinical deployment. Before these tools can be adopted in routine care, prospective, multicenter studies are required that report calibration and clinical utility, adhere to established reporting standards, and demonstrate added value over the current standard of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.